CD47 and neoplasm: Specific T-cell responses against tumors can be induced by anti-CD47 treatment alone in an immunocompetent mouse tumor model.22 Therefore, the overall response (T-cell + macrophages) may be reduced with systemic TMZ chemotherapy in an immunocompetent model as well as in humans.